Around the web

New treatment targets cancers with particular genetic signature

By November 2, 2015 No Comments

Cancer cells with a mutated SETD2 gene were killed by a drug called AZD1775 that inhibits a protein called WEE1 in a recent study. It is well known that mutations drive cancer cell growth and resistance to treatment. However, these mutations can also become a weak point for a tumor. The research team found that that was the case for cancer cells with mutations in a key cancer gene called SETD2.

Read more

Clint Nielsen

Author Clint Nielsen

Clint is a dad and husband trying to stay in shape. He's also a highly opinionated fitness enthusiast and author of Reveal The Steel. Follow him on: Instagram, Twitter, Facebook and Google+

More posts by Clint Nielsen

Leave a Reply